Trademarkia Logo

Canada

C$
Trademark Search in Canada
IPSEN BIOPHARMACEUTICALS CANADA

View On IC.GC.CA

IPSEN BIOPHARMACEUTICALS CANADA
REGISTERED

on 18 Dec 2019

Last Applicant/ Owned by

IPSEN S.A.

65 Quai Georges Gorse92100 Boulogne Billancourt

FR

Serial Number

1702518 filed on 13th Nov 2014

Registration Number

TMA1066761 registered on 18th Dec 2019

Registration expiry Date

18th Dec 2029

Correspondent Address

LAVERY, DE BILLY, LLP

1 Place Ville Marie, Suite 4000Montréal

QUÉBEC

CA

H3B4M4

IPSEN BIOPHARMACEUTICALS CANADA

Trademark usage description

chemicals for use in the manufacture of cosmetic, and chemicals for use in the manufacture of pharmaceutical preparations namely pharmaceutical prepar Read More

Classification Information

Class [001]
Chemicals for use in the manufacture of cosmetic, and chemicals for use in the manufacture of pharmaceutical preparations namely pharmaceutical preparations for use in oncology, pharmaceutical preparations for the treatment of endocrine diseases namely disorders of the thyroid namely thyroid cancer, thyroid nodules, primary hyperparathyroidism, hyperthyroidism, hypothyroidism, thyroiditis, parathyroid, adrenal and pituitary glands, acromegaly, diabetes, hypercosticism, hyperlipoproteinemia, hyperprolactinemia, hypoglycemia, pheochromocytoma, polyuropolydipsic syndrome, pharmaceutical preparations for the treatment of neurological diseases namely neurodegenerative diseases, neurosensory disorders, pain traumatisms, spinal cord injuries, neuromuscular disorders, convulsions, motor and sensory sequelae of cerebral origin, motor and sensory sequelae of medullary injury, cerebellar syndrome, muscle tone disorders and tremors, neurocognitive and neuropsychiatric sequelae, peripheral nervous system damage namely damage to upper and lower limbs, sensory, painful and trophic phenomena, sciatica and cervicobrachialgia, cranial nerve damage, damage linked to certain neurological syndromes namely post-concussion syndrome, epilepsy, parkinsonian syndromes, post-traumatic spinal syndrome, pharmaceutical preparations for the treatment of hematological disorders namely adenopathy, anemia, intravascular coagulation, sickle-cell anemia, monoclonal dysglobulinemia, leukemia, malignant non-Hodgkin's lymphomas, purpura, splenomegaly, hemorrhagic syndrome, mononucleosis syndromes, Hodgkin's disease, multiple myeloma, thalassemia, thrombopenia, polycythemia vera, pharmaceutical preparations for the treatment of gastroenterological diseases and disorders, and for the treatment of cardiovascular and cognitive disorders, pharmaceutical preparations for the treatment of urological diseases, pharmaceutical preparations for the treatment and prevention of neuromuscular disorders namely medicines nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, focal dystonia, cervical dystonia, pharmaceutical preparations for the treatment of muscular disorders namely muscular atrophy, muscular dystrophy, muscular dystonia, muscle spasms, neck strain, cramps, pharmaceutical preparations for the treatment of orthopedic disorders namely hip dislocation, spinal column deformation, curvature of the spine namely scoliosis, lordosis, cyphosis, pharmaceutical preparations for the treatment of disorders relating to age namely senile dementia, emphysema, Alzheimer's, and age-related macular degeneration, pharmaceutical preparations for the relief of pain, muscle spasm, hemifacial spasm and blepharospasm, pharmaceutical preparations for the treatment and prevention of cervical dystonia, torticollis, cerebral palsy, and spasticity, pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, namely dermatitis, eczema, skin lesions, hyperkeratosis, skin irritations, rosacea, psoriasis, acne, wound scars, pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and botulinum toxin derivatives used for the treatment of spasms and dystonias, cervical dystonia, focal dystonia, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, torticollis and cerebral pasly, muscle disorders and muscle spasms, hemifacial spasm and blepharospasm, chronic migraine, severe primary axillary hyperhidrosis, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin namely glabellar lines, wrinkles, and to prevent the development of wrinkles, pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and botulinum toxin derivatives for use in cosmetic surgery

Classification kind code

10

Class [005]
Pharmaceutical preparations for use in oncology, pharmaceutical preparations for the treatment of endocrine diseases namely disorders of the thyroid namely thyroid cancer, thyroid nodules, primary hyperparathyroidism, hyperthyroidism, hypothyroidism, thyroiditis, parathyroid, adrenal and pituitary glands, acromegaly, diabetes, hypercosticism, hyperlipoproteinemia, hyperprolactinemia, hypoglycemia, pheochromocytoma, polyuropolydipsic syndrome, pharmaceutical preparations for the treatment of neurological diseases namely neurodegenerative diseases, neurosensory disorders, pain traumatisms, spinal cord injuries, neuromuscular disorders, convulsions, motor and sensory sequelae of cerebral origin, motor and sensory sequelae of medullary injury, cerebellar syndrome, muscle tone disorders and tremors, neurocognitive and neuropsychiatric sequelae, peripheral nervous system damage namely damage to upper and lower limbs, sensory, painful and trophic phenomena, sciatica and cervicobrachialgia, cranial nerve damage, damage linked to certain neurological syndromes namely post-concussion syndrome, epilepsy, parkinsonian syndromes, post-traumatic spinal syndrome, pharmaceutical preparations for the treatment of hematological disorders namely adenopathy, anemia, intravascular coagulation, sickle-cell anemia, monoclonal dysglobulinemia, leukemia, malignant non-Hodgkin's lymphomas, purpura, splenomegaly, hemorrhagic syndrome, mononucleosis syndromes, Hodgkin's disease, multiple myeloma, thalassemia, thrombopenia, polycythemia vera, pharmaceutical preparations for the treatment of gastroenterological diseases and disorders, and for the treatment of cardiovascular and cognitive disorders; pharmaceutical preparations for the treatment of urological diseases; pharmaceutical preparations for the treatment and prevention of neuromuscular disorders namely medicines nerviness, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, focal dystonia, cervical dystonia; pharmaceutical preparations for the treatment of muscular disorders namely muscular atrophy, muscular dystrophy, muscular dystonia, muscle spasms, neck strain, cramps; pharmaceutical preparations for the treatment of orthopedic disorders namely hip dislocation, spinal column deformation, curvature of the spine namely scoliosis, lordosis, cyphosis; pharmaceutical preparations for the treatment of disorders relating to age namely senile dementia, emphysema, Alzheimer's, and age-related macular degeneration; pharmaceutical preparations for the relief of pain, muscle spasm, hemifacial spasm and blepharospasm; pharmaceutical preparations for the treatment and prevention of cervical dystonia, torticollis, cerebral palsy, and spasticity; pharmaceutical preparations for the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, namely dermatitis, eczema, skin lesions, hyperkeratosis, skin irritations, rosacea, psoriasis, acne, wound scars; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and botulinum toxin derivatives used for the treatment of spasms and dystonias, cervical dystonia, focal dystonia, spasticity of the upper limbs, child spasticity, adult spasticity, focal spasticity, movement disorders, torticollis and cerebral pasly, muscle disorders and muscle spasms, hemifacial spasm and blepharospasm, chronic migraine, severe primary axillary hyperhidrosis, glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin namely glabellar lines, wrinkles, and to prevent the development of wrinkles; pharmaceutical preparations containing botulinum toxin, botulinum toxin-haemagglutin complex, botulinum toxin fragments and botulinum toxin derivatives for use in cosmetic surgery

Classification kind code

10

Class [009]
Computer software for providing information and advertising in the fields of science, health, medicine, pharmacy and beauty

Classification kind code

10

Class [010]
Medical apparatus and instruments, namely medical syringes, medical needles and introducers, needles for injection, needles for medical use, needles and needle free injunction systems, namely injection syringes

Classification kind code

10

Class [016]
Printed matter, namely, pamphlets, books, brochures, newsletters, journals, magazines in the fields of science, health, medicine, pharmacy and beauty

Classification kind code

10

Class [038]
Telecommunications services, namely, transmission of information, data namely text messages, images and sounds via computer terminals and the Internet namely electronic mail services

Classification kind code

10

Class [041]
Training services in the fields of science, health, medicine and beauty; education services, namely, arranging and conducting colloquiums, conferences, conventions, seminars, symposiums in the fields of science, health, medicine, pharmacy and beauty

Classification kind code

10

Class [042]
Scientific, medical and industrial research services and research and development services for new products in the fields of science, health, medicine, pharmacy and beauty; development services of chemical products, proprietary medicines, plants and pharmaceutical procedures in production of pharmacologically active substance and preparations, and of cosmetics; scientific and medical testing and diagnoses of chemical products, pharmaceutical products, cosmetic products, chemical, biological and bacteriological analysis; design and development of computers and software, all above mentioned services provided for others; information services, namely, providing advice and consultations in the field of scientific research

Classification kind code

10

Class [044]
Medical services namely medical clinics, medical counselling namely medical house call services, medical diagnostic, testing services for medical purposes, medical clinics, medical diagnostic services, medical laboratory services, medical research services; providing hygienic and beauty care services for human beings, namely home care services, nursing home services, nursing care services, clinics and hospitals, beauty salons; information services, namely, providing information, advice and consulting services in the fields of scientific research and medicine namely providing medical and scientific research information in the field of pharmaceuticals, cosmetics and clinical trials

Classification kind code

10

Mark Details

Serial Number

1702518

Mark Type

Trademark

Legal History

Show more

Action TakenStatus
Submitted for opposition 15
on 12th Jun 2018		Correspondence Created
Submitted for opposition 12
on 9th Jan 2018		Extension of Time
Submitted for opposition 15
on 4th May 2017		Correspondence Created
Submitted for opposition 15
on 15th Aug 2016		Correspondence Created
Submitted for opposition 15
on 18th Jan 2016		Correspondence Created
Submitted for opposition 22
on 18th Jun 2015		Search Recorded
Submitted for opposition 20
on 18th Jun 2015		Examiner's First Report
Submitted for opposition 31
on 17th Nov 2014		Formalized
Submitted for opposition 30
on 13th Nov 2014		Filed
Submitted for opposition 1
on 13th Nov 2014		Created